We have reached the point where a clinic is offering to run the liquid part of our blood through equipment to remove plastic. I had to stop there for a minute. Plastic in the ocean is already upsetting enough, and now we're talking about a treatment for something that ended up inside us. My first reaction is that I'd really like this to work. My next one is that I want to know what work actually means when somebody is sitting in that chair.
The company is Clarify Clinics, and the procedure is called Clari. It treats plasma, the liquid portion of blood, with a column designed to capture certain unwanted substances. Microplastics are among the things the company says it can remove, which immediately raises a whole collection of questions about what's in our blood and what happens when we try to take it out.
There is real medical technology behind blood processing, and researchers have started studying plastic collected during some of these procedures. Then the questions start branching off. How are they measuring something that small? Where did it come from? Does taking some out mean there's less in the body afterward, and does the person feel or do any better? I started reading about the filter and ended up wondering about the tests, which turns out to be a pretty important detour.
The word plastic puts something much bigger in my head than the things researchers are looking for. I think of a bottle, a wrapper, a recognizable object. Microplastics can be tiny fragments, and nanoplastics are smaller still, far beyond what we could spot floating around without laboratory equipment. That matters here because two tests can both say microplastics while measuring very different sizes. The familiar word makes the results sound easier to compare than they actually are.
One of the studies that brought plastic in blood into the wider conversation was published in Environment International in 2022. Researchers examined samples from twenty-two healthy volunteers and measured several polymers, including PET and polyethylene. You might recognize those names from packaging, although a polymer's name can't tell us which particular bottle or bag it came from.
The researchers used chemical analysis to measure plastic mass. They weren't counting visible little pieces between the blood cells, although that's the picture a headline can leave you with. I find the difference interesting because it changes what we can ask of the result. Knowing a polymer was detected doesn't give us the full history of how it arrived, and it doesn't tell us what removing it would change. I would love the material to come with a little explanation of where it had been, but we're having to work that out ourselves.
The Machine Works With Plasma
Blood has several components doing different jobs. Red blood cells carry oxygen, platelets help with clotting, and plasma carries cells and many dissolved substances around the body. Doctors can separate those components to treat or remove a particular part while returning the others, using a family of procedures called apheresis.
Apheresis already has medical uses. The American College of Rheumatology, for example, describes plasma exchange as a way to remove harmful antibodies in selected illnesses. So the idea of taking blood components out, doing something useful with them and returning what the patient needs has a medical history behind it.
With Clari, the company's description says substances bind to material inside a column through adsorption. Yes, adsorption has an extra d, and it means material attaches to a surface. The treated plasma is then returned along with the blood cells, rather than the person's own plasma simply being discarded.
Not Every Blood-Processing Procedure Does the Same Thing
Another term that comes up is therapeutic plasma exchange, or TPE. In that procedure, plasma is removed and replaced with an appropriate fluid, such as an albumin solution. Clari's approach is to treat and return the person's plasma, so a study of TPE isn't automatically a study of Clari.
This was where I had to go back and separate the procedures in my head. Blood, a machine, something removed, blood returned. It sounds similar enough until you look at what happens to the plasma. One system treats your own plasma and returns it; another removes and replaces it. That changes what a study of one procedure can tell us about the other, even if both stories end up under almost the same headline.
The particle size matters too. Clarify's current website describes removing microplastics and other synthetic particles larger than five microns from plasma. Its page about what the treatment removes identifies the supporting microplastic result as an external bench test based on a four-hour procedure.
Five microns is tiny, but there are particles smaller than that. The stated range doesn't tell us that those smaller particles are caught, or that plastic in other parts of the body has been removed. A bench test also leaves us with questions about what happens during treatment in a person and how long any change lasts afterward.
Researchers Have Found Plastic in What Gets Removed
A short paper published in Brain Medicine in May 2025 described plastic-like material collected during apheresis. The researchers examined twenty-one patient samples using a double-filtration approach. Some authors worked at the clinic providing the treatment, which is relevant when we're reading the findings.
Seeing material in the collected fluid is interesting. Something that appears to have been circulating can now be examined outside the body. I understand why that catches people's attention, because it gives us something to point at after all the talk about particles we can't see. It still leaves the question I keep coming back to: what changed for the person? The contents of the container only show us one part of what happened.
A 2026 paper in the Journal of Clinical Apheresis went further by looking at blood measurements around plasma exchange. It examined 114 patients across 174 procedures. Among procedures with the highest starting measurements, the average fell from 52.2 to 21.1 particles per 100 microliters of blood, a decrease of roughly sixty percent.
That is a substantial change in a blood measurement, and it helps explain the interest. But the result wasn't the same in every group: the lowest starting group had a higher average afterward. The authors suspected that plastic from tubing or related medical materials could be adding particles, which is a frustrating problem when the whole purpose is to remove them.
The method detected particles down to one micron, so it couldn't establish nanoplastic removal. All authors had connections to the company or clinics providing plasma exchange, and the study didn't show whether total plastic throughout the body fell or health improved. It also studied plasma exchange, rather than directly testing Clari.
The tubing detail really bothered me. We're using equipment to try to remove plastic while wondering whether the equipment could be contributing particles too. Of course medicine and laboratory work use plastic, because it's useful for an enormous number of things. We keep ending up back at that same problem: the material is everywhere in part because it does so many jobs well. Now that makes it harder to work out what was in a sample before we touched it.
The FDA explains that researchers still lack standardized ways of sampling, detecting and characterizing these particles. One test might estimate the mass of particular polymers, while another counts particles within a size range. Both can produce a number, but they aren't necessarily telling us the same thing.
Laboratories use controls to help identify contamination introduced during handling and analysis. Smaller particles make the work harder still. So if somebody offers a commercial blood test, the method and its limits matter much more than whether the result arrives looking satisfyingly precise.
And then there's the question of what a particular number means for our health. We need research showing which measurements predict a problem and whether changing them helps. Otherwise, it's very easy to end up with an alarming number and an expensive way to lower it, without knowing enough about what the change accomplishes.
There's a Reason Scientists Are Taking This Seriously
A 2024 study in the New England Journal of Medicine found an association between plastic detected in carotid artery plaque and later cardiovascular events or death. The participants were having surgery for carotid artery disease. It was an observational study, so it couldn't establish that plastic caused those outcomes, and it wasn't testing a plastic-removal treatment.
I understand why hearing about plastic in artery plaque is frightening. It's a part of the body where I don't want to be thinking about packaging materials at all. But an association in people having surgery for artery disease doesn't tell us that filtering somebody else's blood will prevent a heart attack. I want the research to get us closer to that answer, rather than having the worry run ahead of what a treatment has actually shown.
If a procedure helps people sleep better, feel better, or avoid illness, those would be things I'd want to know about. A person describing how they felt afterward matters as an experience, but it can't by itself tell us what caused the change or how often somebody else would get it. This is the frustrating part of wanting something to be useful while still needing more than a persuasive story about it. The person taking on the procedure deserves that answer.
A Comfortable Room Doesn't Change What the Procedure Involves
Plasma processing means blood leaves the body and passes through equipment, with medical access and trained supervision. NHS information on therapeutic plasma exchange describes possible problems such as low blood pressure, reactions and changes in calcium levels. The risk of infection or bleeding also depends partly on how access is established, and the exact risks vary with the procedure and patient.
That doesn't make every procedure inappropriate; doctors weigh risks against expected benefits when treating established medical problems. It does mean an elective treatment with an uncertain benefit still needs a convincing medical reason. Comfortable chairs are lovely, but I'd want to be just as clear about what was happening if the room looked a great deal less impressive.
PFAS and Microplastics Aren't Interchangeable
PFAS also appear in descriptions of some blood treatments. They're a large group of manufactured chemicals, and the Environmental Protection Agency describes ongoing work on exposure and health effects. A measurement of those chemicals answers a different question from a count of plastic particles.
This can get lost when a brochure groups everything under the word toxins. I understand the appeal of one word for all the things we'd rather keep out of our bodies, but the substances still have their own chemistry. Evidence about removing one doesn't automatically establish what happens to another, however convenient it would be if they all behaved the same way.
The European Food Safety Authority describes microplastics being released as larger materials wear down, including synthetic textiles and car tires. Exposure can involve food, water and air. A treatment deals with the material it can reach during that session, while the surroundings we return to remain part of our exposure.
I've written about switching to glass food storage, which is where my mind tends to go when a story like this starts feeling too big. There's a container in front of me and a choice I can probaly make without reading another paper. I can follow the food-container instructions, use durable things where they make sense, and cut back on disposable packaging. I can't honestly turn that into a percentage change in my blood, though. That would take a different kind of evidence from me feeling better about the leftovers.
We also deserve to be able to eat lunch without turning every meal into an investigation. The FDA says important gaps remain in understanding the health effects of the levels detected in foods. Scientists are still working through the measurement and risk questions, which is a good reason to keep following the research without assuming every frightening claim has already been established.
I keep thinking about how strange the whole sequence is. We made a material that was useful and lasted, used it in almost everything, and now we're finding small pieces in places we never meant it to go. Some of the equipment we're trying to use to understand that problem also depends on plastic. There isn't a tidy place to stand outside it all, which is probably why the promise of simply taking it back out feels so appealing.
I'd be glad to see convincing evidence that removing circulating plastic makes people healthier, because that would give us something useful to do with all this concern. For now, the measurements and the treatment questions still need work. I'm interested in where the research goes, and I'll keep using the glass containers without pretending they've solved the whole thing. I really would like us to get better at dealing with the plastic before it reaches our veins in the first place.
I’m very happy to make room for a set of glass food containers in the kitchen. Cook a little extra, put tomorrow’s lunch where I can see it and give the leftovers their own very useful place.
Sources
Clarify Clinics: stated particle range and bench-test qualification
Leslie et al., 2022: plastic polymers measured in blood samples
Weinstein et al., 2026: microplastic measurements before and after plasma exchange
Marfella et al., 2024: artery-plaque findings and cardiovascular outcomes
University Hospitals Birmingham NHS: plasma exchange information and risks
FDA: microplastics, measurement challenges, and health evidence
Related Reads from the Archive
Why I Switched from Plastic Tupperware to Glass (and the Science That Finally Convinced Me)
Plastic Rocks: The Rise of Plastistone and What It Says About Us
The Plant That Eats Metal: How Rinorea niccolifera Could Clean the Earth
The Fungus in the Backpack: A Quiet Arrest, a Toxic Threat, and the Strange Future of Biosecurity